EE301 Cost-Effectiveness Analysis of Avelumab Plus Best Supportive Care (BSC) As First-Line Maintenance Treatment in Locally Advanced or Metastatic Urothelial Carcinoma (La/mUC) in France
Abstract
Authors
I Plessala H Cawston J Roiz Y Xiao M Kearney J Chang F Porte A Granghaud A Morel A Ravaud Y Loriot A Thiery-Vuillemin P Levy